By Caroline Humer and Deena Beasley SAN FRANCISCO (Reuters) - Eli Lilly and Co said on Monday that U.S. insurers are increasing pressure on the price of diabetes medications as they switch coverage from certain drugs to others to trim costs. At the same time, Lilly's financial chief believes its products produce better results for patients and will help the company, which is one of the largest diabetes drugmakers, withstand the pressure. The comments come after Lilly competitor Sanofi SA warned in October that U.S. pricing pressure on its Lantus diabetes medication would hurt 2015 results. ... via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment